534 related articles for article (PubMed ID: 18559517)
1. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
[TBL] [Abstract][Full Text] [Related]
2. Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling.
Li X; Wang Y; Sharif-Afshar AR; Uwamariya C; Yi A; Ishii K; Hayward SW; Matusik RJ; Bhowmick NA
Differentiation; 2009 Jan; 77(1):95-102. PubMed ID: 19281768
[TBL] [Abstract][Full Text] [Related]
3. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.
Li X; Placencio V; Iturregui JM; Uwamariya C; Sharif-Afshar AR; Koyama T; Hayward SW; Bhowmick NA
Oncogene; 2008 Nov; 27(56):7118-30. PubMed ID: 18724388
[TBL] [Abstract][Full Text] [Related]
4. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
Li X; Martinez-Ferrer M; Botta V; Uwamariya C; Banerjee J; Bhowmick NA
Oncogene; 2011 Jan; 30(2):167-77. PubMed ID: 20818421
[TBL] [Abstract][Full Text] [Related]
5. A reciprocal role of prostate cancer on stromal DNA damage.
Banerjee J; Mishra R; Li X; Jackson RS; Sharma A; Bhowmick NA
Oncogene; 2014 Oct; 33(41):4924-31. PubMed ID: 24141771
[TBL] [Abstract][Full Text] [Related]
6. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
[TBL] [Abstract][Full Text] [Related]
7. Stromal TGF-β signaling induces AR activation in prostate cancer.
Yang F; Chen Y; Shen T; Guo D; Dakhova O; Ittmann MM; Creighton CJ; Zhang Y; Dang TD; Rowley DR
Oncotarget; 2014 Nov; 5(21):10854-69. PubMed ID: 25333263
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells.
Boomershine CS; Chamberlain A; Kendall P; Afshar-Sharif AR; Huang H; Washington MK; Lawson WE; Thomas JW; Blackwell TS; Bhowmick NA
Gut; 2009 Sep; 58(9):1267-74. PubMed ID: 19625278
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.
Bhowmick NA; Chytil A; Plieth D; Gorska AE; Dumont N; Shappell S; Washington MK; Neilson EG; Moses HL
Science; 2004 Feb; 303(5659):848-51. PubMed ID: 14764882
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
12. Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure.
Martinez-Ferrer M; Afshar-Sherif AR; Uwamariya C; de Crombrugghe B; Davidson JM; Bhowmick NA
Am J Pathol; 2010 Jan; 176(1):98-107. PubMed ID: 19959810
[TBL] [Abstract][Full Text] [Related]
13. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.
Song K; Wang H; Krebs TL; Kim SJ; Danielpour D
Cancer Res; 2008 Oct; 68(19):8173-82. PubMed ID: 18829577
[TBL] [Abstract][Full Text] [Related]
14. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation.
Fitchev PP; Wcislak SM; Lee C; Bergh A; Brendler CB; Stellmach VM; Crawford SE; Mavroudis CD; Cornwell ML; Doll JA
Lab Invest; 2010 Jul; 90(7):1078-90. PubMed ID: 20458281
[TBL] [Abstract][Full Text] [Related]
16. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
Wikström P; Bergh A; Damber JE
Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N
Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062
[TBL] [Abstract][Full Text] [Related]
19. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
20. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
